Interleukin 6 plasma concentration associates with cognitive decline: The Northern Manhattan study

Neuroepidemiology

Volumn 40, Issue 4, 2013, Pages 253-259

  Economos, Alexis ^a   Wright, Clinton B ^a   Moon, Yeseon Park ^b   Rundek, Tatjana ^a   Rabbani, Leroy ^b   Paik, Myunghee C ^c   Sacco, Ralph L ^a   Elkind, Mitchell S V ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Departments of Neurology Leonard M Miller School of Medicine University of Miami ^*  (United States)

^c Departments of Epidemiology and Public Health Leonard M Miller School of Medicine University of Miami ^*  (United States)

Author keywords

Cognitive decline; Cohort studies; Inflammation; Interleukin 6

Indexed keywords

APOLIPOPROTEIN E4; INTERLEUKIN 6;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL DETERIORATION; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; SMOKING; TELEPHONE INTERVIEW;

EID: 84873052328     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000343276     Document Type: Article

References (36)

1. Welsh P, Lowe GD, Chalmers J, Campbell DJ, Rumley A, Neal BC, MacMahon SW, Woodward M: Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 2008; 39: 2226-2230.
2. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH: Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 1997; 94: 1500-1505.
3. McGeer EG, McGeer PL: The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998; 33: 371-378.
4. Wright CB, Elkind MSV, Rundek T, Boden-Albala B, Paik MC, Sacco RL: Alcohol intake, carotid plaque, and cognition: The Northern Manhattan Study. Stroke 2006; 37: 1160-1164.
5. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frolich M, Hofman A, Jolles J, Breteler MM, Westendorp RG: Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 2007; 55: 708-716.
6. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T: Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003; 61: 76-80.
7. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE: Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002; 59: 371-378.
8. Gimeno D, Marmot MG, Singh-Manoux A: Inflammatory markers and cognitive function in middle-aged adults: The Whitehall II Study. Psychoneuroendocrinology 2008; 33: 1322-1334
9. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P: Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005; 64: 1371-1377.
10. Patterson CC, Smith AE, Yarnell JW, Rumley A, Ben-Shlomo Y, Lowe GD: The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: The Caerphilly Study. Atherosclerosis 2010; 209: 551-557.
11. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242.
12. Van Exel E, de Craen AJM, Remarque EJ, Gussekloo J, Houx P, Bootsma-van der Wiel A, Frolich M, Macfarlane PW, Blauw GJ, Westendorp RGJ: Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology 2003; 61: 1695-1701.
13. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Rumley A, Lowe GD, Fowkes FG: Cognitive decline and markers of inflammation and hemostasis: The Edinburgh Artery Study. J Am Geriatr Soc 2007; 55: 700-707.
14. Wright CB, Sacco RL, Rundek T, Delman JB, Rabbani LE, Elkind MSV: Interleukin-6 is associated with cognitive function: The Northern Manhattan Study. J Stroke Cerebrovasc Dis 2006; 15: 34-38.
15. Jordanova V, Stewart R, Davies E, Sherwood R, Prince M: Markers of inflammation and cognitive decline in an African-Caribbean population. Int J Geriatr Psychiatry 2007; 22: 966-973.
16. Gurland BJ, Wilder DE, Lantigua R, Stern Y, Chen J, Killeffer EH, Mayeux R: Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry 1999; 14: 481-493.
17. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, Merchant C, Lantigua R, Costa R, Stern Y, Mayeux R: Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001; 56: 49-56.
18. Wright CB, Lee HS, Paik MC, Stabler SP, Allen RH, Sacco RL: Total homocysteine and cognition in a tri-ethnic cohort: The Northern Manhattan Study. Neurology 2004; 63: 254-260.
19. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC: The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999; 281: 53-60.
20. Sacco RL, Gan R, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC: Leisure-time physical activity and ischemic stroke risk: The Northern Manhattan Stroke Study. Stroke 1998; 29: 380-387.
21. Hamilton M: The Hamilton Depression Rating Scale. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
22. Brandt J, Spencer M, Folstein MF: The Telephone Interview for Cognitive Status. Neuropsychiatry Neuropsychol Behav Neurol 1988; 1: 111-117.
23. Khatri M, Nickolas T, Moon YP, Paik MC, Rundek T, Elkind MS, Sacco RL, Wright CB: CKD associates with cognitive decline. J Am Soc Nephrol 2009; 20: 2427-2432.
24. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
25. Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Lowe V, Kantarci K, Bernstein MA, Senjem ML, Gunter JL, Boeve BF, Trojanowski JQ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Knopman DS: Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol 2012, E-pub ahead of print.
26. Tso AR, Merino JG, Warach S: Interleukin-6 174G/C polymorphism and ischemic stroke: A systematic review. Stroke 2007; 38: 3070-3075.
27. Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, Sacco RL: High-sensitivity C-reactive protein predicts mortality but not stroke: The Northern Manhattan Study. Neurology 2009; 73: 1300-1307.
28. Cerhan JR, Folsom AR, Mortimer JA, Shahar E, Knopman DS, McGovern PG, Hays MA, Crum LD, Heiss G: Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998; 44: 95-105.
29. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, Juo SH, Sacco RL: Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: The Northern Manhattan Prospective Cohort Study. Stroke 2002; 33: 1420-1423.
30. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR: Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry 2008; 64: 484-490.
31. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JCM, Breteler MMB: Inflammatory proteins in plasma and the risk of dementia: The Rotterdam Study. Arch Neurol 2004; 61: 668-672.
32. Banks WA, Kastin AJ, Broadwell RD: Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995; 2: 241-248.
33. Picotte M, Campbell CG, Thorland WG: Day-to-day variation in plasma interleukin-
34. concentrations in older adults. Cytokine 2009; 47: 162-165.
35. Rao KM, Pieper CS, Currie MS, Cohen HJ: Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 1994; 102: 802-805.
36. Gabay C: Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8(suppl 2): S3.